Table 6 HIV antibody prevalence and undiagnosed infection in community samples of MSM in selected countries
Location | Year conducted | Recruitment sites | Sample size* | HIV prevalence (%) | Proportion undiagnosed (%) | Ref |
|---|---|---|---|---|---|---|
England (3 cities) | 2003-4 | GB, GS | 348 | 8.6% Manchester | 36.7% Manchester | |
| Â | Â | Â | 1436 | 12.3% London | 44.1% London | Â |
| Â | Â | Â | 373 | 13.7% Brighton | 33.3% Brighton | Â |
Scotland (2 cities) | 2005 | GB, GS | 749 | 3.6% Glasgow | 48.1% Glasgow | |
| Â | Â | Â | 601 | 5.5% Edinburgh | 36.4% Edinburgh | Â |
Southern Africa (3 countries) | 2008 | SB | 537 | 17.4% | 76.3% | [16] |
United States (21 cities) | 2008 | GB, SO | 8153 | 19.2% overall | 43.5% overall | [17] |
| Â | Â | Â | Â | 6.4% Atlanta (low) | 15.4% Seattle (low) | Â |
| Â | Â | Â | Â | 37.8% Baltimore (high) | 73.4% Baltimore (high) | Â |
Australia (2 cities) | 2008 | GB, GS | 465 | 8.8% Brisbane | 19.5% Brisbane | [18] |
| Â | Â | Â | 639 | 9.5% Melbourne | 31.1% Melbourne | [12] |
France (Paris) | 2009 | GB, GS | 886 | 17.7% | 20% | Â |
New Zealand (Auckland) | 2011 | GB, GS, CE | 1049 | 6.5% | 20.9% | [19] |